Steve Sabus

Steve Sabus

Senior Vice President and Chief Commercial Officer

Steve Sabus serves as senior vice president and chief commercial officer. Mr. Sabus has over 30 years of industry experience in directing Sales, Marketing and Commercial functions at leading biopharmaceutical companies.

Prior to Turning Point, Mr. Sabus spent 15 years in roles with increasing levels of sales responsibility at Astellas Pharma, most recently serving as the head of Oncology leading a group of over 300 team members. In this role he provided executive leadership to scale the company’s $3 billion U.S. oncology franchise by launching and growing new products. His achievements include successfully expanding the market for Xtandi®, directing the ongoing launch of Padcev®, and developing the commercial strategy for the potential launch of zolbetuximab, an investigational monoclonal antibody therapy targeting Claudin18.2. Before Astellas, Steve spent 16 years at Johnson & Johnson in roles of increasing responsibility in the Commercial organization.

Turning Point Therapeutics is now a
Bristol Myers Squibb company

Select OK for information about Turning Point Therapeutics.

Select BMS to learn more about Bristol Myers Squibb